Clinical Trials
3 trialsNCT04493619 2024-11-04
PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
Opna Bio LLC
Phase 1/2 Terminated
NCT02499952 2022-07-11
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Hoosier Cancer Research Network
Phase 2 Terminated
NCT03993210 2020-12-02
The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids
Dana-Farber Cancer Institute
Phase NA Terminated